Search Results - "Huben, R P"

Haematogenous dissemination of cells from human renal adenocarcinomas by GLAVES, D, HUBEN, R. P, WEISS, L

“…Estimates were made of the rates at which cancer cells were released directly into the renal vein in patients undergoing radical nephrectomy for primary renal…”
Get full text

NCCN Practice Guidelines for Prostate Cancer by Bahnson, R R, Hanks, G E, Huben, R P, Kantoff, P, Kozlowski, J M, Kuettel, M, Lange, P H, Logothetis, C, Pow-Sang, J M, Roach, 3rd, M, Sandler, H, Scardino, P T, Taylor, R J, Urban, D A, Walsh, P C, Wilson, T G

“…Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced…”
Get more information

A comparison of diethylstilbestrol or orchiectomy with buserelin and with methotrexate plus diethylstilbestrol or orchiectomy in newly diagnosed patients with clinical stage D2 cancer of the prostate by Huben, R P, Murphy, G P

“…From April 1983 to March 1985, 265 patients with newly diagnosed metastatic prostate cancer were randomized to one of three treatment protocols: (1)…”
Get more information

Results of surgical treatment of renal cell carcinoma with solitary metastasis by Dineen, M K, Pastore, R D, Emrich, L J, Huben, R P

“…To determine the effect on survival of excision of a solitary metastasis from renal cell carcinoma, the records of 29 patients seen at our institute within the…”
Get more information

Adrenal adenocarcinoma: a review of 53 cases by Zografos, G C, Driscoll, D L, Karakousis, C P, Huben, R P

“…Fifty-three patients (30 men, 23 women) with histologically proven adrenal carcinoma were reviewed. Nineteen (36%) had endocrine manifestations from…”
Get more information

The use of transrectal ultrasound in the detection and evaluation of local pelvic recurrences after a radical urological pelvic operation by Parra, R O, Wolf, R M, Huben, R P

“…Transrectal ultrasound was performed in 20 patients with suspected local pelvic recurrence after a radical pelvic operation: 9 had undergone radical…”
Get more information

Effect of perioperative chemoimmunotherapy with cyclophosphamide and autologous tumor vaccine in murine MBT-2 bladder cancer by Tzai, T S, Huben, R P, Zaleskis, G, Berleth, E S, Ehrke, M J, Mihich, E

“…The in vitro cytotoxic activity of splenocytes from C3H/He mice implanted subcutaneously with 10(6) syngeneic MBT-2 tumor cells on day 0 was significantly…”
Get more information

Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder by Pan, J S, Slocum, H K, Rustum, Y M, Greco, W R, Gaeta, J F, Huben, R P

“…This study was designed to determine the role of immediate intravesical instillation of single dose thiotepa post transurethral resection of bladder tumor in…”
Get more information

Primary renal sarcoma by Spellman, Jr, J E, Driscoll, D L, Huben, R P

“…Primary renal sarcoma represents approximately 1 per cent of all primary tumors of the kidney. The purpose of this study is to review the experience at Roswell…”
Get more information

Chylous ascites and lymphocyst management by peritoneovenous shunt by Silk, Y N, Goumas, W M, Douglass, Jr, H O, Huben, R P

“…Although lymphocyst (retroperitoneal lymphocele) is not an uncommon complication after retroperitoneal surgery, with a reported incidence ranging from 0.6% to…”
Get more information

Phase I clinical trial of recombinant human tumor necrosis factor by CREAVEN, P. J, PLAGER, J. E, DUPERE, S, HUBEN, R. P, TAKITA, H, MITTELMAN, A, PROEFROCK, A

“…A phase I and pharmacokinetic study of recombinant tumor necrosis factor (rH-TNF Asahi) was carried out in 29 patients, who received a total of 72 courses with…”
Get full text

Salvage surgery following radical radiotherapy for adenocarcinoma of the prostate by Mador, D R, Huben, R P, Wajsman, Z, Pontes, J E

“…The development and proliferation of modern radiotherapy techniques, and their application in the 1970s to the treatment of localized adenocarcinoma of the…”
Get more information

Assessment of human genitourinary tumors and chemosensitivity testing in 3-dimensional collagen gel culture by Perrapato, S D, Slocum, H K, Huben, R P, Ghosh, R, Rustum, Y

“…A recently described collagen gel culture technique has been modified to evaluate the growth characteristics and chemosensitivity patterns of genitourinary…”
Get more information

Prognostic factors in localized prostatic carcinoma by Pontes, J E, Wajsman, Z, Huben, R P, Wolf, R M, Englander, L S

“…Serial histological sections were performed in 54 radical prostatectomy specimens in an attempt to identify prognostic factors responsible for dissemination of…”
Get more information

Interferon-beta treatment of metastatic prostate cancer by Bulbul, M A, Huben, R P, Murphy, G P

“…A limited clinical trial of Interferon-beta (Human Fibroblast Interferon) in the treatment of advanced, hormone-refractory prostate cancer was conducted by the…”
Get more information

Locally recurrent endometrioid adenocarcinoma of the prostate after radical prostatectomy by Perrapato, S D, Shah, P C, Huben, R P, Gaeta, J F

“…Endometrioid carcinoma of the prostate is considered a variant of classical prostatic ductal carcinoma. Endometrioid carcinoma variant often has the unique…”
Get more information

Prognostic factors in survival of bladder cancer by Lopez-Beltran, A, Croghan, G A, Croghan, I, Huben, R P, Mettlin, C, Gaeta, J F

“…Clinical and pathologic data of 36 patients with transitional cell carcinoma of the bladder were investigated to determine the significance on patient survival…”
Get more information

Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa by Zein, T, Wajsman, Z, Englander, L S, Gamarra, M, Lopez, C, Huben, R P, Pontes, J E

“…We report a prospective study of 136 patients with biopsy proved bladder tumor who underwent 311 evaluations with cystoscopy, urinary cytology, bladder washing…”
Get more information

Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer by Murphy, G P, Huben, R P, Priore, R

“…From July, 1980, to June, 1983, 319 patients with newly diagnosed metastatic prostatic cancer were randomized to one of three treatment protocols:…”
Get more information

Protection of germinal epithelium with luteinizing hormone-releasing hormone analogue by Nseyo, U O, Huben, R P, Klioze, S S, Pontes, J E

“…A dog model for chemotherapy and radiation-induced testicular damage was created to study the protective potential of superactive analogue of luteinizing…”
Get more information